News from the healthcare data industry
Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis December 15, 2022 07:00 AM Eastern Standard Time CAMBRIDGE,...
Real world database fosters innovation for vulnerable populations November 08, 2022 09:00 AM Eastern Standard Time MISSISSAUGA, Ontario–(BUSINESS WIRE)–PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access...
TEL AVIV, Israel, Feb. 10, 2022 /PRNewswire/ —CytoReason, a leading developer of computational disease models for efficient drug discovery and development, today announced the extension of its collaboration agreement with Pfizer. “The...
Pfizer India has signed a Memorandum of Understanding (MoU) with Max Super Specialty Hospitals to give fellowships to young doctors in 17 Max Hospitals to gather real-world evidence on drug...
BELLEVUE, Wash., June 21, 2022 (GLOBE NEWSWIRE) — Truveta today announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable real-world data at...
NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced overall survival (OS) results from the Phase 3 PALOMA-2 trial, which evaluated IBRANCE® (palbociclib) in combination with letrozole compared to placebo plus...
Syapse will continue to identify, validate, and address discrepancies in real-world data, producing an accurate and fully contextualized narrative of a patient’s experience January 20, 2022 10:00 ET | Source: Syapse …...
— Israeli case-control study finds vaccine effective 2 to 4 weeks following second dose by Molly Walker, Deputy Managing Editor, MedPage September 28, 2021 The Pfizer-BioNTech COVID-19 vaccine (Comirnaty) was effective...